Who We Are


A great number of people and organisations have contributed to Open PHACTS since the project’s inception in 2011. We thank everyone who has been involved for their contributions.


Foundation Members

Contributions and support from our members are what keep the Open PHACTS Discovery Platform operating. There are currently four members of the Open PHACTS Foundation, representatives of whom make up our governing board of directors.

Find out more about the benefits of Open PHACTS Foundation membership

GlaxoSmithKline

Representative:
Stefan Senger

Email Stefan »

Janssen Pharmaceutica

Representative:
Herman van Vlijmen

Email Herman »

Eli Lilly & Company

Representative:
Derek Marren

Email Derek »

University of Vienna

Representative:
Gerhard Ecker

Email Gerhard »


Project Consortium

Open PHACTS began as an Innovative Medicines Initiative (IMI) project, aiming to reduce the barriers to drug discovery in industry, academia and small businesses. This project was realised by the Open PHACTS Consortium, with contributors from all areas of life science research including industry, academia, publishing and not-for-profit organisations.

Consortium_Logo_Cloud

 


Associated Partners

We thank our Associated Partners for their continued support and willingness to exchange ideas, data and technology. If you would like to become an Associated Partner of Open PHACTS, please let us know.


Scientific Advisory Board

Our Scientific Advisory Board is comprised of a group of experts who have advised the development and dissemination of the Open PHACTS Discovery Platform with respect to scientific disciplines.